Dupixent 300 MG/2 ML pen 2ML
Ended Awarded Last action
- Contract number
- SPE2DR26FA4F3
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $17,160
Award facts
- Contract value 100% obligated
- $17,160.28 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on January 30, 2026, for the supply of Dupixent 300 mg/2 ml pen injections valued at $17,160.28, with completion anticipated by February 2, 2026. This firm fixed-price delivery order represents a non-competitive, non-set-aside award and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The contract is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical, a comprehensive $999,999,999 global pharmaceutical support vehicle valued through December 2026 that enables the company to supply a broad portfolio of pharmaceutical products and medical supplies to military healthcare programs worldwide.
AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., is a major pharmaceutical distributor and critical federal medical procurement vendor that specializes in supplying both brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains. The company's federal contracting portfolio demonstrates extensive experience fulfilling Defense Logistics Agency requirements through competitively awarded delivery orders with firm fixed pricing, ranging from small transactions to orders exceeding $45,000. This Dupixent delivery order supports the Department of Defense's medical supply needs for treatment of allergic and inflammatory conditions across military treatment facilities and veteran healthcare programs.
Quick answers
Who was awarded contract SPE2DR26FA4F3?
SPE2DR26FA4F3 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 30, 2026.
How much is contract SPE2DR26FA4F3 worth?
The government has obligated $17,160 on SPE2DR26FA4F3.
Is contract SPE2DR26FA4F3 an order under another contract?
Yes. SPE2DR26FA4F3 is a delivery order under SPE2DR25D2014, an indefinite delivery contract.
Was contract SPE2DR26FA4F3 competed?
The extent of competition for SPE2DR26FA4F3 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award